Screening for paraneoplastic antibodies and antibodies for demyelinating conditions such as myelin oligodendrocyte glycoprotein (MOG) antibody disease (MOGAD) and neuromyelitis optica (NMO) was negative. This evidence concerns the gene OMG and neuromyelitis optica.